Moleculin Biotech Inc. (MBRX)
NASDAQ: MBRX
· Real-Time Price · USD
0.67
0.02 (3.43%)
At close: Aug 15, 2025, 3:59 PM
0.69
2.85%
After-hours: Aug 15, 2025, 07:43 PM EDT
Moleculin Biotech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 126K | 126K | 126K | 406K | 406K | 406K | 406K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 62K | 93K | 94K | 129K | 130K | 130K | 238K | 231K | 243K | 246K | 228K | 234K | 224K | 230K | 265K | 231K | 197K | 157K |
Gross Profit | 1K | -30K | -31K | -129K | -130K | -130K | -238K | -231K | -243K | -246K | -228K | -234K | -224K | -230K | -265K | -231K | -197K | -157K |
Operating Income | -25.44M | -25.91M | -26.64M | -28.92M | -27.73M | -27.95M | -29.63M | -27.76M | -30.9M | -31.92M | -30.64M | -28.8M | -25.87M | -23.95M | -22.97M | -21.26M | -21.25M | -20.77M |
Interest Income | 179K | 338K | 549K | 764K | 986K | 1.22M | 1.37M | 1.31M | 1.02M | 671K | 321K | 184K | 238K | 291K | 306K | 239K | 155K | 67K |
Pretax Income | -26.55M | -23.23M | -21.76M | -30.15M | -25.17M | -26.82M | -29.77M | -26.27M | -29.27M | -30.07M | -29.02M | -25.08M | -20.85M | -18.32M | -15.89M | -15.71M | -14.72M | -20.59M |
Net Income | -26.55M | -23.23M | -21.76M | -30.15M | -25.17M | -26.82M | -29.26M | -24.62M | -27.59M | -28.39M | -27.64M | -24.84M | -20.64M | -18.11M | -15.89M | -15.71M | -14.72M | -20.59M |
Selling & General & Admin | 8.9M | 8.87M | 8.79M | 8.88M | 9.34M | 9.8M | 10.08M | 10.66M | 11.12M | 11.79M | 11.54M | 10.7M | 9.63M | 8.87M | 8.39M | 8.06M | 7.7M | 6.91M |
Research & Development | 16.42M | 16.91M | 17.73M | 19.91M | 18.25M | 18.05M | 19.49M | 17.03M | 19.72M | 20.03M | 18.97M | 17.97M | 16.1M | 14.93M | 14.42M | 13.03M | 13.37M | 13.65M |
Other Expenses | 122K | 124K | 125K | 94K | 95K | 73K | 49K | 81K | 81K | 87K | 111K | 89K | 70K | 63K | 40K | 26K | 23K | 32K |
Operating Expenses | 25.44M | 25.91M | 26.64M | 28.88M | 27.69M | 27.92M | 29.6M | 27.76M | 30.9M | 31.92M | 30.64M | 28.8M | 25.87M | 23.95M | 22.97M | 21.26M | 21.25M | 20.77M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.72M | 25.91M | 26.64M | 28.92M | 27.73M | 27.95M | 29.63M | 27.76M | 30.9M | 31.92M | 30.64M | 28.8M | 25.87M | 23.95M | 22.97M | 21.26M | 21.25M | 20.77M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -508K | -1.65M | -1.68M | -1.68M | -1.38M | -240K | -207K | -207K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 15.53M | 93.44K | 3.38M | 3.71M | 2.54M | 2.47M | 2M | 1.99M | 1.98M | 1.92M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.9M | 1.9M | 1.45M |
Shares Outstanding (Diluted) | 15.53M | 93.44K | 3.38M | 3.71M | 2.54M | 2.47M | 2M | 1.99M | 1.98M | 1.92M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.9M | 1.9M | 1.45M |
EPS (Basic) | -72.78 | -73.99 | -7.13 | -11.7 | -11.67 | -12.99 | -14.83 | -12.65 | -14.32 | -14.86 | -14.5 | -13.03 | -10.84 | -9.52 | -9.08 | -11.03 | -13.7 | -26.76 |
EPS (Diluted) | -72.78 | -73.99 | -7.13 | -11.7 | -11.67 | -12.99 | -14.83 | -12.65 | -14.32 | -14.86 | -14.5 | -13.03 | -10.84 | -9.52 | -9.08 | -11.03 | -13.7 | -26.76 |
EBITDA | -25.32M | -25.78M | -26.51M | -28.79M | -27.6M | -27.82M | -29.5M | -27.79M | -30.92M | -31.94M | -30.66M | -28.66M | -25.73M | -23.8M | -22.8M | -21.08M | -21.06M | -20.57M |
EBIT | -19.72M | -25.91M | -26.64M | -28.92M | -27.73M | -27.95M | -29.63M | -27.76M | -30.9M | -31.92M | -30.64M | -28.8M | -25.87M | -23.95M | -22.97M | -21.26M | -21.25M | -20.77M |
Depreciation & Amortization | 123K | 125K | 126K | 130K | 130K | 130K | 238K | 231K | 243K | 246K | 228K | 234K | 224K | 230K | 265K | 277K | 299K | 311K |